JJ
Therapeutic Areas
Arcus Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Casdatifan (AB521) | Renal Cell Carcinoma | Phase 3 |
| Domvanalimab (AB154) | Multiple Solid Tumors (e.g., NSCLC) | Phase 3 |
| Zimberelimab (AB122) | Multiple Solid Tumors | Phase 3 |
| Quemliclustat (AB680) | Pancreatic Cancer | Phase 2/3 |
| AB598 | Advanced Solid Tumors | Phase 1 |
| Etrumadenant (AB928) | Various Solid Tumors | Phase 2 |